Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Kite Pharma, Gilead Sciences’ cell-therapy subsidiary, and Gadeta, an Utrecht, Netherlands-based company developing cancer immunotherapies based on gamma delta T cell receptors (TCRs), have formed a pact to develop gamma delta TCR therapies in...

A roundup of the latest market developments from the pipelines of the pharmaceutical majors, featuring news from AbbVie, Amgen, and UCB. Editor's Note: This article was updated on a continuous basis for news announced from Wednesday July 11, 2018...

A roundup of the latest drug approvals, including from the pharmaceutical majors, featuring news from Pfizer, and Astellas Pharma. Editor's Note: This article was updated on a continuous basis for news announced from Wednesday July 11 to...

Moderna Therapeutics, a Cambridge, Massachusetts-based biotechnology company focusing on messenger RNA (mRNA) therapeutics, has opened a new manufacturing facility in Norwood, Massachusetts for clinical development of mRNA therapeutics. The...

AbbVie has signed patent license agreements with Mylan over Mylan’s proposed biosimilar to AbbVie’s Humira (adalimumab). Humira is AbbVie’s top-selling drug with 2017 sales of $18.43 billion. Under the agreements, AbbVie will grant Mylan a...

The US Food and Drug Administration (FDA) has issued draft guidance, Innovative Approaches for Nonprescription Drug Products, as part of the agency’s effort to increase access to nonprescription drugs to increase drug competition. “While the FDA...

MedImmune, AstraZeneca’s global biologics research and development arm, has partnered with 4D Molecular Therapeutics (4DMT), a company specializing in gene-therapy vector discovery and product development, to develop and commercialize a gene...

The US Food and Drug Administration (FDA) has formed a new Drug Shortages Task Force that will be led by Keagan Lenihan, the FDA’s Associate Commissioner for Strategic Initiatives. The task force is being charged to delve into why some drug...

Genmab A/S, a Copenhagen, Denmark-based biopharmaceutical company developing therapeutic anti-cancer antibodies, has formed a license pact with Immatics Biotechnologies GmbH, a Tuebingen, Germany-based clinical-stage biopharmaceutical company, to...